Liam Condon Buys 27 Shares of Johnson Matthey PLC (LON:JMAT) Stock

Johnson Matthey PLC (LON:JMAT) insider Liam Condon acquired 27 shares of the firm’s stock in a transaction that occurred on Wednesday, October 16th. The shares were purchased at an average cost of GBX 1,505 ($19.65) per share, with a total value of £406.35 ($530.62).

Liam Condon also recently made the following trade(s):

• On Wednesday, September 18th, Liam Condon bought 21 shares of Johnson Matthey stock. The shares were purchased at an average cost of GBX 1,598 ($20.87) per share, with a total value of £335.58 ($438.21).

Johnson Matthey Price Performance

Shares of Johnson Matthey stock opened at GBX 1,525 ($19.91) on Friday. The firm has a fifty day moving average price of GBX 1,563.48 and a two-hundred day moving average price of GBX 1,667.28. Johnson Matthey PLC has a fifty-two week low of GBX 1,428.50 ($18.65) and a fifty-two week high of GBX 1,917.07 ($25.03). The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76. The company has a market cap of £2.66 billion, a PE ratio of 2,629.31, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 2,400 ($31.34) price objective on shares of Johnson Matthey in a research note on Monday, June 24th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,993.33 ($26.03).

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.